Opko Health (NYSE: OPK) has completed the acquisition of Cytochroma Inc. (Markham, Canada). Cytochroma’s lead products include CTAP101 Capsules, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE